Knockdown of SOD2 induced a significant reduction in viability upon treatment with asparaginase (Figures 2A–2F) but did not sensitize leukemic cells to other commonly used leukemia chemotherapeutic agents (Figures 2G–2J). This evidence concerns the gene SOD2 and leukemia.